Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial
- Resource Type
- Article
- Source
- In
The Lancet Oncology May 2024 25(5):658-667 - Subject
Primary Research Articles - Language
- ISSN
- 1470-2045